Flow Diverter Stents for the Endovascular Treatment of Ruptured Intracranial Aneurysms: An Analysis of a Case Series

血流导向支架在破裂性颅内动脉瘤血管内治疗中的应用:病例系列分析

阅读:1

Abstract

Objective This study aimed to describe the clinical outcomes, complications, and aneurysm occlusion of patients with aneurysmal subarachnoid hemorrhage treated with a flow diverter in our institute. Methods This is a retrospective study of the clinical and imaging characteristics in patients with aneurysmal subarachnoid hemorrhage treated by endovascular approach using a flow diverter device from January 2019 to May 2024 at the Specialty Hospital, La Raza National Medical Center, Mexico. The information was obtained through the analysis of clinical records and imaging. Imaging controls were obtained through digital subtraction angiography (DSA) and/or CT angiography (CTA) performed during the 12 months post-treatment. For statistical analysis, IBM SPSS Statistics for Windows, Version 25.0 (IBM Corp., Armonk, New York, United States), was used, with normality assessed using the Shapiro-Wilk test. Data were expressed as absolute frequencies, percentages, mean, and standard deviation. Additionally, the results are presented in descriptive tables for each patient. Results Fifteen patients were analyzed, of whom 73.3% were women and 26.7% were men. No patient experienced rebleeding or died during the 12-month follow-up period. On the 12-month follow-up imaging studies, 14 patients (93.3%) showed complete aneurysm occlusion. Three patients (20%) presented parent vessel occlusion associated with the flow diverter. Thirteen patients (86.7%) had a favorable functional outcome (modified Rankin scale (mRS) 0-2). Conclusions The use of flow diverters in patients with ruptured intracranial aneurysms can be considered an effective and viable alternative in carefully selected cases. Prospective studies with larger sample sizes are needed to evaluate their efficacy and safety.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。